Page last updated: 2024-10-30

labetalol and Hospital-Acquired Condition

labetalol has been researched along with Hospital-Acquired Condition in 1 studies

Labetalol: A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.
labetalol : A diastereoisomeric mixture of approximately equal amounts of all four possible stereoisomers ((R,S)-labetolol, (S,R)-labetolol, (S,S)-labetalol and (R,R)-labetalol). It is an adrenergic antagonist used to treat high blood pressure.
2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide : A member of the class of benzamides that is benzamide substituted by a hydroxy group at position 2 and by a 1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl group at position 5.

Research Excerpts

ExcerptRelevanceReference
"Circulatory collapse and obtundation occurred in a 37-year-old woman following an iatrogenic overdose of labetalol."3.69Labetalol overdose successfully treated with amrinone and alpha-adrenergic receptor agonists. ( Kollef, MH, 1994)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kollef, MH1

Other Studies

1 other study available for labetalol and Hospital-Acquired Condition

ArticleYear
Labetalol overdose successfully treated with amrinone and alpha-adrenergic receptor agonists.
    Chest, 1994, Volume: 105, Issue:2

    Topics: Adrenergic alpha-Agonists; Adult; Amrinone; Cardiac Output, Low; Drug Overdose; Female; Humans; Iatr

1994